BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6186978)

  • 1. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematological prospect in 1981, particularly in the field of coagulation and fibrinolysis.
    Abe T
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):11-16. PubMed ID: 6810621
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural inhibitors of the coagulation system.
    Messmore HL
    Semin Thromb Hemost; 1982 Oct; 8(4):267-75. PubMed ID: 6184781
    [No Abstract]   [Full Text] [Related]  

  • 5. The biochemistry and pathophysiology of the contact system of plasma.
    Cochrane CG; Griffin JH
    Adv Immunol; 1982; 33():241-306. PubMed ID: 6182767
    [No Abstract]   [Full Text] [Related]  

  • 6. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 7. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.
    Colman RW; Schmaier AH
    Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood coagulation and fibrinolysis inhibitory factors].
    Imaoka S; Sasaki Y; Terasawa T
    Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical problems of the natural coagulation and fibrinolysis inhibitors--introduction (author's transl)].
    Aoki N
    Rinsho Ketsueki; 1978 Jul; 19(7):917-9. PubMed ID: 81326
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
    J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of components of the coagulation systems in normal individuals and septic shock patients.
    Smith-Erichsen N; Aasen AO; Gallimore MJ; Amundsen E
    Circ Shock; 1982; 9(5):491-7. PubMed ID: 7172424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitors.
    Schapira M; James A; Scott CF; Kueppers F; James HL; Cohen AB; Colman RW
    Adv Exp Med Biol; 1983; 156():131-41. PubMed ID: 6190364
    [No Abstract]   [Full Text] [Related]  

  • 17. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates.
    Keuren JF; Magdeleyns EJ; Bennaghmouch A; Bevers EM; Curvers J; Lindhout T
    Br J Haematol; 2007 Aug; 138(4):527-33. PubMed ID: 17608769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemistry of coagulation.
    Mann KG
    Clin Lab Med; 1984 Jun; 4(2):207-20. PubMed ID: 6238784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
    Dubin A; Potempa J; Travis J
    Prep Biochem; 1990; 20(1):63-74. PubMed ID: 1694995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.